主动脉内球囊反搏与院外心脏骤停后良好神经功能生存:多中心前瞻性倾向评分匹配研究
该研究基于日本大阪多中心前瞻性观察登记(CRITICAL),纳入2012年7月至2016年12月连续成人非创伤性院外心脏骤停恢复自主循环患者2894例,其中10.4%使用主动脉内球囊反搏,89.6%未使用。主要终点为1个月良好神经功能生存。全部患者中主动脉内球囊反搏组良好神经功能生存比例高于未使用组(30.7% vs 13.2%),但倾向评分匹配后两组几乎一致,无显著差异(37.3% vs 41.1%;调整OR 0.97,95%CI 0.48-1.96)。结论认为在当前人群中未发现主动脉内球囊反搏使用与1个月良好神经功能生存的关联。
要点
- 在倾向评分匹配的成人非创伤性院外心脏骤停恢复自主循环患者中,主动脉内球囊反搏使用组与未使用组1个月良好神经功能生存无显著差异(37.3% vs 41.1%;调整OR 0.97,95%CI 0.48-1.96)。
- 全部患者中主动脉内球囊反搏组1个月良好神经功能生存比例高于未使用组(30.7% vs 13.2%),但该差异在倾向评分匹配后消失。
- 研究纳入2894例成人非创伤性院外心脏骤停恢复自主循环患者,主动脉内球囊反搏使用率为10.4%。
- 该多中心前瞻性观察性倾向评分匹配分析未显示主动脉内球囊反搏使用与1个月良好神经功能生存相关。
适用人群与场景
- 日本大阪连续成人(≥18岁)非创伤性院外心脏骤停且恢复自主循环的患者,纳入时间为2012年7月至2016年12月。
研究设计与关键结果
- 多中心前瞻性观察性登记研究(CRITICAL研究),纳入2894例成人非创伤性院外心脏骤停恢复自主循环患者,其中10.4%使用主动脉内球囊反搏,89.6%未使用。
- 全部患者中,主动脉内球囊反搏组1个月良好神经功能生存比例为30.7%(92/300),未使用组为13.2%(342/2594)。
- 倾向评分匹配后,主动脉内球囊反搏组1个月良好神经功能生存比例为37.3%(59/158),未使用组为41.1%(65/158),两组几乎一致,无显著差异(调整OR 0.97,95%CI 0.48-1.96)。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察性登记研究,采用倾向评分匹配分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该倾向评分匹配分析未显示主动脉内球囊反搏使用与成人院外心脏骤停恢复自主循环后1个月良好神经功能生存相关,原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to evaluate whether intra-aortic balloon pump (IABP) use in nontraumatic out-of-hospital cardiac arrest (OHCA) patients who achieved return of spontaneous circulation (ROSC) is associated with favorable neurological outcome after OHCA.
BACKGROUND: The association between the IABP use in OHCA patients and favorable neurological outcome has not been extensively evaluated.
METHODS: The Comprehensive Registry of Intensive Cares for OHCA Survival (CRITICAL) study, a multicenter, prospective observational registry in Osaka, Japan, included consecutive nontraumatic OHCA patients aged ≥18 years who achieved ROSC from July 2012 to December 2016. The primary outcome was 1-month survival with favorable neurological outcome. Logistic regression analysis was used to evaluate the association between the IABP use or non-IABP use and favorable neurological outcome using one-to-one propensity score (PS) matching analysis.
RESULTS: Among the 2894 eligible patients, 10.4% used IABP, and 89.6% did not use IABP. In all patients, the proportion of 1-month survival with favorable neurological outcome was higher in the IABP use group than in the non-IABP use group (30.7% [92/300] vs. 13.2% [342/2594]). However, in PS-matched patients, the proportions of 1-month survival with favorable neurological outcome were almost consistent, and there were no significant differences between the IABP use group and the non-IABP use group (37.3% [59/158] vs. 41.1% [65/158]; adjusted odds ratio, 0.97; 95% confidence interval, 0.48-1.96).
CONCLUSIONS: In this population, the current PS matching analysis did not reveal any association between the IABP use and 1-month survival with favorable neurological outcome among adult patients with ROSC after OHCA.
参考来源
- Kishimori T, Matsuyama T, Yamada T, et al. Intra-aortic balloon pump and survival with favorable neurological outcome after out-of-hospital cardiac arrest: A multicenter, prospective propensity score-matched study. Resuscitation. 2019. PMID: 31302105. doi:10.1016/j.resuscitation.2019.07.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。